Role of nitric oxide in the regulation of myocardial function - PubMed (original) (raw)
Review
Role of nitric oxide in the regulation of myocardial function
J M Hare et al. Prog Cardiovasc Dis. 1995 Sep-Oct.
Abstract
Nitric oxide (NO), produced by either constitutive or inducible isoforms of NO synthase (cNOS or iNOS), influences myocardial inotropic and chronotropic responses. This pathway has been studied using NO donors or NOS inhibitors or by immune-mediated stimulation of iNOS. Although inhibition of constitutive NO activity in the heart does not influence indices of myocardial contractility, NO donors, in some species and preparations, may exert a negative inotropic effect as well as an enhancement of diastolic relaxation. The best documented cardiac action of NO is inhibition of the positive inotropic and chronotropic responses to beta-adrenergic receptor stimulation. Basal NO production, presumable via cNOS, appears to exert a mild tonic inhibition of beta-adrenergic responses. On the other hand, excessive NO production mediated by iNOS may contribute to the myocardial depression and beta-adrenergic hyporesponsiveness associated with conditions such as sepsis, myocarditis, cardiac transplant rejection, and dilated cardiomyopathy. Muscarinic cholinergic stimulation of the heart appears to stimulate NO production that mediates, at least partially, parasympathetic slowing of heart rate and inhibition of beta-adrenergic contractility. NO-stimulated production of 3',5'-cyclic guanosine monophosphate via guanylyl cyclase accounts for many of the observed physiological actions of NO. 3',5'-Cyclic guanosine monophosphate inhibits the beta-adrenergic-stimulated increase in the slow-inward calcium current and reduces the calcium affinity of the contractile apparatus, actions that could contribute to a negative inotropic effect, an abbreviation of contraction, and an enhancement of diastolic relaxation. Biochemical, immunocytochemical, and molecular biological techniques have been used to show the presence of both cNOS and iNOS within the myocardium. cNOS is expressed in myocytes, endothelial cells, and neurons in the myocardium, and there is evidence for iNOS in myocytes, small vessel endothelium, vascular smooth muscle cells, and immune cells that infiltrate the heart. Taken together, these observations suggest that NO influences normal cardiac physiology and may play an important role in the pathophysiology of certain disease states associated with cardiac dysfunction.
Similar articles
- Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R. Vandecasteele G, et al. Nat Med. 1999 Mar;5(3):331-4. doi: 10.1038/6553. Nat Med. 1999. PMID: 10086391 - The influence of endothelium-derived nitric oxide on myocardial contractile function.
Shah AM, Prendergast BD, Grocott-Mason R, Lewis MJ, Paulus WJ. Shah AM, et al. Int J Cardiol. 1995 Jul;50(3):225-31. doi: 10.1016/0167-5273(95)02381-6. Int J Cardiol. 1995. PMID: 8537145 Review. - Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure.
Gealekman O, Abassi Z, Rubinstein I, Winaver J, Binah O. Gealekman O, et al. Circulation. 2002 Jan 15;105(2):236-43. doi: 10.1161/hc0202.102015. Circulation. 2002. PMID: 11790707 - Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea-pig atria.
Choate JK, Paterson DJ. Choate JK, et al. J Auton Nerv Syst. 1999 Feb 15;75(2-3):100-8. doi: 10.1016/s0165-1838(98)00173-8. J Auton Nerv Syst. 1999. PMID: 10189110 - Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences.
Balligand JL, Cannon PJ. Balligand JL, et al. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1846-58. doi: 10.1161/01.atv.17.10.1846. Arterioscler Thromb Vasc Biol. 1997. PMID: 9351345 Review.
Cited by
- Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
D'Agostino A, Lanzafame LG, Buono L, Crisci G, D'Assante R, Leone I, De Vito L, Bossone E, Cittadini A, Marra AM. D'Agostino A, et al. Int J Mol Sci. 2023 Dec 19;25(1):36. doi: 10.3390/ijms25010036. Int J Mol Sci. 2023. PMID: 38203205 Free PMC article. Review. - Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target.
Liu B, Tewari AK, Zhang L, Green-Church KB, Zweier JL, Chen YR, He G. Liu B, et al. Biochim Biophys Acta. 2009 Mar;1794(3):476-85. doi: 10.1016/j.bbapap.2008.12.008. Epub 2008 Dec 25. Biochim Biophys Acta. 2009. PMID: 19150419 Free PMC article. - Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms.
Flynn A, Chokkalingam Mani B, Mather PJ. Flynn A, et al. Heart Fail Rev. 2010 Nov;15(6):605-11. doi: 10.1007/s10741-010-9176-4. Heart Fail Rev. 2010. PMID: 20571889 Review. - Evidence for impaired vagus nerve activity in heart failure.
Bibevski S, Dunlap ME. Bibevski S, et al. Heart Fail Rev. 2011 Mar;16(2):129-35. doi: 10.1007/s10741-010-9190-6. Heart Fail Rev. 2011. PMID: 20820912 Review. - Small dedifferentiated cardiomyocytes bordering on microdomains of fibrosis: evidence for reverse remodeling with assisted recovery.
Al Darazi F, Zhao W, Zhao T, Sun Y, Marion TN, Ahokas RA, Bhattacharya SK, Gerling IC, Weber KT. Al Darazi F, et al. J Cardiovasc Pharmacol. 2014 Sep;64(3):237-46. doi: 10.1097/FJC.0000000000000111. J Cardiovasc Pharmacol. 2014. PMID: 24785345 Free PMC article.